These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22908174)

  • 1. Randomized controlled trial of the safety and efficacy of Daptomycin versus standard-of-care therapy for management of patients with osteomyelitis associated with prosthetic devices undergoing two-stage revision arthroplasty.
    Byren I; Rege S; Campanaro E; Yankelev S; Anastasiou D; Kuropatkin G; Evans R
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5626-32. PubMed ID: 22908174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.
    Lalani T; Boucher HW; Cosgrove SE; Fowler VG; Kanafani ZA; Vigliani GA; Campion M; Abrutyn E; Levine DP; Price CS; Rehm SJ; Corey GR; Karchmer AW;
    J Antimicrob Chemother; 2008 Jan; 61(1):177-82. PubMed ID: 17999973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daptomycin for Pediatric Gram-Positive Acute Hematogenous Osteomyelitis.
    Bradley JS; Arrieta AC; Digtyar VA; Popejoy MW; Grandhi A; Bokesch P; Hershberger E; Dorr MB; Tan CM; Murata Y; Wolf DJ; Bensaci M
    Pediatr Infect Dis J; 2020 Sep; 39(9):814-823. PubMed ID: 32639465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Daptomycin-nonsusceptible vancomycin-intermediate staphylococcus aureus vertebral osteomyelitis cases complicated by bacteremia treated with high-dose daptomycin and trimethoprim-sulfamethoxazole.
    Avery LM; Steed ME; Woodruff AE; Hasan M; Rybak MJ
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5990-3. PubMed ID: 22869580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of daptomycin as first-line treatment for complicated skin and soft tissue infections in elderly patients: an open-label, multicentre, randomized phase IIIb trial.
    Konychev A; Heep M; Moritz RK; Kreuter A; Shulutko A; Fierlbeck G; Bouylout K; Pathan R; Trostmann U; Chaves RL
    Drugs Aging; 2013 Oct; 30(10):829-36. PubMed ID: 23990341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Therapy, Microbiological Findings, and Comorbidity Influence the Outcome of Prosthetic Joint Infections Undergoing 2-Stage Exchange.
    Ascione T; Pagliano P; Balato G; Mariconda M; Rotondo R; Esposito S
    J Arthroplasty; 2017 Jul; 32(7):2239-2243. PubMed ID: 28372916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter evaluation of the clinical outcomes of daptomycin with and without concomitant β-lactams in patients with Staphylococcus aureus bacteremia and mild to moderate renal impairment.
    Moise PA; Amodio-Groton M; Rashid M; Lamp KC; Hoffman-Roberts HL; Sakoulas G; Yoon MJ; Schweitzer S; Rastogi A
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1192-200. PubMed ID: 23254428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daptomycin treatment in patients with resistant staphylococcal periprosthetic joint infection.
    Chang YJ; Lee MS; Lee CH; Lin PC; Kuo FC
    BMC Infect Dis; 2017 Nov; 17(1):736. PubMed ID: 29187163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
    Fowler VG; Boucher HW; Corey GR; Abrutyn E; Karchmer AW; Rupp ME; Levine DP; Chambers HF; Tally FP; Vigliani GA; Cabell CH; Link AS; DeMeyer I; Filler SG; Zervos M; Cook P; Parsonnet J; Bernstein JM; Price CS; Forrest GN; Fätkenheuer G; Gareca M; Rehm SJ; Brodt HR; Tice A; Cosgrove SE;
    N Engl J Med; 2006 Aug; 355(7):653-65. PubMed ID: 16914701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
    Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
    J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates.
    Rehm SJ; Boucher H; Levine D; Campion M; Eisenstein BI; Vigliani GA; Corey GR; Abrutyn E
    J Antimicrob Chemother; 2008 Dec; 62(6):1413-21. PubMed ID: 18782781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive rifampin is crucial to optimizing daptomycin efficacy against rabbit prosthetic joint infection due to methicillin-resistant Staphylococcus aureus.
    Saleh-Mghir A; Muller-Serieys C; Dinh A; Massias L; Crémieux AC
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4589-93. PubMed ID: 21825285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synovial Cytokines and the MSIS Criteria Are Not Useful for Determining Infection Resolution After Periprosthetic Joint Infection Explantation.
    Frangiamore SJ; Siqueira MB; Saleh A; Daly T; Higuera CA; Barsoum WK
    Clin Orthop Relat Res; 2016 Jul; 474(7):1630-9. PubMed ID: 26821163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin-resistant Staphylococcal periprosthetic joint infections can be effectively controlled by systemic and local daptomycin.
    Kuo FC; Yen SH; Peng KT; Wang JW; Lee MS
    BMC Infect Dis; 2016 Feb; 16():48. PubMed ID: 26830838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective observational study comparing vancomycin versus daptomycin as initial therapy for Staphylococcus aureus infections.
    Jobson S; Moise PA; Eskandarian R
    Clin Ther; 2011 Oct; 33(10):1391-9. PubMed ID: 22015328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Multicenter Study Comparing Safety and Efficacy of Daptomycin Versus Standard-of-care in Pediatric Patients With Staphylococcal Bacteremia.
    Arrieta AC; Bradley JS; Popejoy MW; Bensaci M; Grandhi A; Bokesch P; Glasser C; Du L; Patino H; Kartsonis NA
    Pediatr Infect Dis J; 2018 Sep; 37(9):893-900. PubMed ID: 29406465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series.
    Rao N; Regalla DM
    Clin Orthop Relat Res; 2006 Oct; 451():34-7. PubMed ID: 16735866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2019 John Charnley Award: Increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis.
    Wyles CC; Hevesi M; Osmon DR; Park MA; Habermann EB; Lewallen DG; Berry DJ; Sierra RJ
    Bone Joint J; 2019 Jun; 101-B(6_Supple_B):9-15. PubMed ID: 31146571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Adams K
    Antimicrob Agents Chemother; 1989 May; 33(5):689-92. PubMed ID: 2546488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors governing the healing of Staphylococcus aureus infections following hip and knee prosthesis implantation: a retrospective study of 95 patients.
    Joulie D; Girard J; Mares O; Beltrand E; Legout L; Dezèque H; Migaud H; Senneville E
    Orthop Traumatol Surg Res; 2011 Nov; 97(7):685-92. PubMed ID: 22000281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.